Oncternal Therapeutics, Inc.

Organization

San Diego, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compounds for treatment of cancer
- Patent number 11,465,987
- Issue date Oct 11, 2022
- Oncternal Therapeutics, Inc.
- Wei Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Uses of indolinone compounds
- Patent number 11,285,132
- Issue date Mar 29, 2022
- Oncternal Therapeutics, Inc.
- Brian Lannutti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for treatment of cancer
- Patent number 11,084,811
- Issue date Aug 10, 2021
- Oncternal Therapeutics, Inc.
- Wei Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for treatment of cancer
- Patent number 10,865,196
- Issue date Dec 15, 2020
- University of Tennessee Research Foundation
- Duane D. Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-invasive method of evaluating breast cancers for selective andr...
- Patent number 10,849,873
- Issue date Dec 1, 2020
- Oncternal Therapeutics, Inc.
- Mitchell S. Steiner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indoline analogs and uses thereof
- Patent number 10,711,008
- Issue date Jul 14, 2020
- Oncternal Therapeutics, Inc.
- Stephen E. Webber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Uses of indolinone compounds
- Patent number 10,646,470
- Issue date May 12, 2020
- Oncternal Therapeutics, Inc.
- Brian Lannutti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective androgen receptor degrader (SARD) ligands and methods of...
- Patent number 10,597,354
- Issue date Mar 24, 2020
- University of Tennessee Research Foundation
- Ramesh Narayanan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indoline analogs and uses thereof
- Patent number 10,351,569
- Issue date Jul 16, 2019
- Oncternal Therapeutics, Inc.
- Stephen E. Webber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Uses of indolinone compounds
- Patent number 10,159,660
- Issue date Dec 25, 2018
- Oncternal Therapeutics, Inc.
- Brian Lannutti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indolinone compounds and uses thereof
- Patent number 9,987,251
- Issue date Jun 5, 2018
- Oncternal Therapeutics, Inc.
- Jean-Michel Vernier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indolinone compounds and uses thereof
- Patent number 9,895,352
- Issue date Feb 20, 2018
- Oncternal Therapeutics, Inc.
- Jean-Michel Vernier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indoline analogs and uses thereof
- Patent number 9,822,122
- Issue date Nov 21, 2017
- Oncternal Therapeutics, Inc.
- Stephen E. Webber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indolinone compounds and uses thereof
- Patent number 9,604,927
- Issue date Mar 28, 2017
- Oncternal Therapeutics, Inc.
- Jean-Michel Vernier
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
COMBINATIONS OF EGFR INHIBITORS AND ROR1 INHIBITORS FOR THE TREATME...
- Publication number 20230070988
- Publication date Mar 9, 2023
- Oncternal Therapeutics, Inc.
- Gunnar KAUFMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF...
- Publication number 20230041951
- Publication date Feb 9, 2023
- University of Tennessee Research Foundation
- Ramesh Narayanan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLINONE COMPOUNDS AND USES THEREOF
- Publication number 20220288023
- Publication date Sep 15, 2022
- Oncternal Therapeutics, Inc.
- Jean-Michel Vernier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TREATMENT OF CANCER
- Publication number 20220024912
- Publication date Jan 27, 2022
- Oncternal Therapeutics, Inc.
- Wei LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF...
- Publication number 20210024458
- Publication date Jan 28, 2021
- Oncternal Therapeutics, Inc.
- Ramesh NARAYANAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF INDOLINONE COMPOUNDS
- Publication number 20200253927
- Publication date Aug 13, 2020
- Oncternal Therapeutics, Inc.
- Brian Lannutti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF...
- Publication number 20200222365
- Publication date Jul 16, 2020
- Oncternal Therapeutics, Inc.
- Ramesh NARAYANAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLINE ANALOGS AND USES THEREOF
- Publication number 20190337951
- Publication date Nov 7, 2019
- Oncternal Therapeutics, Inc.
- Stephen E. Webber
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF INDOLINONE COMPOUNDS
- Publication number 20190022062
- Publication date Jan 24, 2019
- Oncternal Therapeutics, Inc.
- Brian Lannutti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLINONE COMPOUNDS AND USES THEREOF
- Publication number 20180256546
- Publication date Sep 13, 2018
- Oncternal Therapeutics, Inc.
- Jean-Michel Vernier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF INDOLINONE COMPOUNDS
- Publication number 20180028495
- Publication date Feb 1, 2018
- Oncternal Therapeutics, Inc.
- Brian Lannutti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLINE ANALOGS AND USES THEREOF
- Publication number 20170349600
- Publication date Dec 7, 2017
- Oncternal Therapeutics, Inc.
- Stephen E. Webber
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDOLINE ANALOGS AND USES THEREOF
- Publication number 20170283420
- Publication date Oct 5, 2017
- Oncternal Therapeutics, Inc.
- Stephen E. Webber
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDOLINONE COMPOUNDS AND USES THEREOF
- Publication number 20170065559
- Publication date Mar 9, 2017
- Oncternal Therapeutics, Inc.
- Jean-Michel Vernier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLINONE COMPOUNDS AND USES THEREOF
- Publication number 20170066720
- Publication date Mar 9, 2017
- Oncternal Therapeutics, Inc.
- Jean-Michel Vernier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDOLINONE COMPOUNDS AND USES THEREOF
- Publication number 20160102055
- Publication date Apr 14, 2016
- Tokalas, Inc.
- Jean-Michel Vernier
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
88515236 - ONCTERNAL
- Serial number 88515236
- Registration number 6116257
- Filing date Jul 15, 2019
- Oncternal Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto

NIH Research Projectlast 12 months

processing...

Count: 2

Research Projects

Information Research Project
First-in-class ETS inhibitor TK216: Translational Biology and Oral...
- Application id 10259473
- Award notice date Aug 23, 2021
Information Research Project
Selective Androgen Receptor Degraders (SARDs) as new therapeutics f...
- Application id 10259452
- Award notice date Aug 19, 2021

Oncternal Therapeutics, Inc.

Organization

Patents Grantslast 30 patents

Compounds for treatment of cancer

Uses of indolinone compounds

Compounds for treatment of cancer

Compounds for treatment of cancer

Non-invasive method of evaluating breast cancers for selective andr...

Indoline analogs and uses thereof

Uses of indolinone compounds

Selective androgen receptor degrader (SARD) ligands and methods of...

Indoline analogs and uses thereof

Uses of indolinone compounds

Indolinone compounds and uses thereof

Indolinone compounds and uses thereof

Indoline analogs and uses thereof

Indolinone compounds and uses thereof

Patents Applicationslast 30 patents

COMBINATIONS OF EGFR INHIBITORS AND ROR1 INHIBITORS FOR THE TREATME...

SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF...

INDOLINONE COMPOUNDS AND USES THEREOF

COMPOUNDS FOR TREATMENT OF CANCER

SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF...

USES OF INDOLINONE COMPOUNDS

SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF...

INDOLINE ANALOGS AND USES THEREOF

USES OF INDOLINONE COMPOUNDS

INDOLINONE COMPOUNDS AND USES THEREOF

USES OF INDOLINONE COMPOUNDS

INDOLINE ANALOGS AND USES THEREOF

INDOLINE ANALOGS AND USES THEREOF

INDOLINONE COMPOUNDS AND USES THEREOF

INDOLINONE COMPOUNDS AND USES THEREOF

INDOLINONE COMPOUNDS AND USES THEREOF

Trademarklast 30 trademarks

88515236 - ONCTERNAL

NIH Research Projectlast 12 months

Research Projects

First-in-class ETS inhibitor TK216: Translational Biology and Oral...

Selective Androgen Receptor Degraders (SARDs) as new therapeutics f...